Breast cancer
Breast cancer, one of the most common cancers among women globally, arises from breast tissue, typically from the inner lining of mammary ducts or the lobules supplying them. Breast cancer can present as a lump in the breast, changes in breast shape, dimpling of the skin, or abnormal nipple discharge. While the exact causes remain complex and multifactorial, risk factors include genetics, age, lifestyle, and hormonal influences. Early detection, primarily through mammography screening, significantly improves prognosis and survival rates. Treatment options tailored to each individual may include surgery, chemotherapy, radiation therapy, and hormone or targeted therapies. Recent advancements in research are focusing on understanding the molecular subtypes of breast cancer, leading to more personalized and effective treatment strategies. Breast cancer awareness and education campaigns emphasize the importance of regular screenings and self-examinations in early detection and successful treatment outcomes.
Breast cancer
Latest Posts
-
Vitamin D and Breast Cancer survival
Women with higher vitamin D levels in their blood following a breast cancer diagnosis had significantly better long-term outcomes, according to new research from Kaiser Permanente and Roswell Park Cancer Institute. The study was published in JAMA…
-
Synthetic binding protein called “NS1 Monobody” found to inhibit common cancer causing (RAS) mutation
Monobody NS1 binds to H-RAS or K-RAS protein and blocksRAS function by disrupting the protein’s ability to form active molecular pairs. Credit: John P. O’Bryan, et al. Researchers at the University of Illinois at Chicago have identified a new…
-
Synthetic binding protein called "NS1 Monobody" found to inhibit common cancer causing (RAS) mutation
Monobody NS1 binds to H-RAS or K-RAS protein and blocksRAS function by disrupting the protein’s ability to form active molecular pairs. Credit: John P. O’Bryan, et al. Researchers at the University of Illinois at Chicago have identified a new…
-
Role of Prolactin Inducible Protein in Breast Cancer
Researchers describe the first evidence linking prolactin inducible protein (PIP) to the immune system’s ability to recognize and destroy foreign cells, such as tumor cells. New research in prolactin inducible protein deficient mice that demonstrates the role of…
-
Understanding pathology behind triple negative breast cancer
A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patient and may help them avoid unnecessary and invasive…
-
Tamoxifen and Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community health
In patients with invasive breast cancer treated in a general community health care setting, Tamoxifen, Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community and that risk progressively decreased as the duration of…
-
Improving participation in cancer screening should be a priority
Early diagnosis of cancer is linked to better survival rates. Unfortunately, participation rates for cancer screening worldwide are low even when screening programmes are free. The ESMO 2016 Congress is showcasing five studies (1) on this important…
-
Neoadjuant PARP inhibitor treatment shrinks tumors in BRCA-positive breast cancer patients
All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson…
You must be logged in to post a comment.